Nectar Lifesciences Q3 Results

  • BSE: 532649
  • NSE: NECLIFE
  • ISIN: INE023H01027
  • Sector: Biotechnology & Drugs
BSE
33.32-0.68 (-2.00%)
Volume27.31 K
Updated: Mon 25 Nov, 2024 | 15:15:00
NSE
32.95-0.64 (-1.91%)
Volume7.24 L
Updated: Mon 25 Nov, 2024 | 15:15:07
Today: 33.32
33.32
52-Wk: 25.02
56.39

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Nectar Lifesciences Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 452.17397.96-%344.13-%
    Selling/ General/ Admin Expenses Total 21.6220.31-%19.71-%
    Depreciation/ Amortization 15.3715.31-%14.78-%
    Other Operating Expenses Total 60.9963.00-%52.56-%
    Total Operating Expense 425.35386.41-%357.46-%
    Operating Income 26.8211.55-%-13.34-%
    Net Income Before Taxes 2.461.64-%-17.56-%
    Net Income 1.571.02-%-9.29-%
    Diluted Normalized EPS 0.070.05-%-0.41-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts